The objective of this report is to examine the development of pharmacovigilance (PV) in Ghana and illustrate the role it plays in the health system, and more recently, during the COVID-19 emergency response. It concludes by offering some relevant lessons for building PV capacity in other low-and middle-income countries.
Authors
Wang,Huihui, Darko, Delese Mimi, Figueras Sune,Albert-Jesus, Marquez,Patricio V., Kumwenda,James Kondwani
- Disclosure Date
- 2023/09/18
- Disclosure Status
- Disclosed
- Doc Name
- From Vertical Program Activity to Nationwide System : Ghana's Pharmacovigilance Experience - Ghana Case Study
- Product Line
- Advisory Services & Analytics
- Published in
- United States of America
- Rel Proj ID
- 1W-Kwpf Hnp-Asa For Covid 19 -- P174615,1W-Capacity Building In Africa For Resilient Health System -- P168344
- Sector
- Health-HG
- Series Name
- Pharmacovigilance and Essential Public Health Functions/Service;
- TF No/Name
- TF0B3871-HNP Programmatic Technical Assistance for Tackling COVID-19
- Theme
- Health Systems and Policies,Human Development and Gender,Private Sector Delivery in Health,Reproductive and Maternal Health,Health Finance,Health Service Delivery,Health System Strengthening,Child Health,Adolescent Health,Health Systems and Policies,Human Development and Gender,Disease Control,Health System Strengthening,Pandemic Response,Health Service Delivery
- Unit Owning
- HNP Global (HHNGE)
- Version Type
- Final
- Volume No
- 1
